Abstract
Background: Central nervous system is a very rare site of Kaposi's sarcoma in acquired immunodeficiency syndrome. Kaposi's sarcoma, a neoplasm of endothelial origin, occurs mainly in the skin, but can involve many tissues, especially in patients with a poor immunity. Combination antiretroviral therapy, highly active against human immunodeficiency virus type-1, has caused a dramatic reduction of cutaneous and visceral involvements. No report of central nervous system localization of Kaposi's sarcoma is described since the introduction of combination antiretroviral therapy in the late 90's. Case presentation: A 42 year-old Caucasian man affected by human immunodeficiency virus type-1 infection treated with combination antiretroviral therapy and showing relatively preserved immunity with low viral load presented gingival squamous cell carcinoma and visceral (lungs and lymph nodes) Kaposi's sarcoma. Chemotherapy and radiotherapy were performed with improvement of both neoplasms. Afterwards, a magnetic resonance imaging showed focal lesions of the brain. Despite new chemotherapy and radiotherapy the patient died. Histology after autopsy revealed brain lesions due to Kaposi's sarcoma with the detection of Human Herpesvirus 8 on tissue samples. Conclusions: This is the first report in the combination antiretroviral therapy era of a very rare complication of Kaposi's sarcoma, such as that of brain localization, in a patient with a relatively good control of human immunodeficiency virus infection. Therefore, Kaposi's sarcoma should be considered in differential diagnosis with other intracranial mass lesions that can occur in human immunodeficiency virus infected-patients focusing the issue of appropriate treatment for central nervous system involvement.
| Original language | English |
|---|---|
| Article number | 600 |
| Journal | BMC Infectious Diseases |
| Volume | 13 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Dec 21 2013 |
Fingerprint
Keywords
- Central nervous system
- Combination antiretroviral therapy
- HHV-8
- HIV
- Kaposi's sarcoma
ASJC Scopus subject areas
- Infectious Diseases
Cite this
Brain localization of Kaposi's sarcoma in a patient treated by combination antiretroviral therapy. / Baldini, Francesco; Baiocchini, Andrea; Schininà, Vincenzo; Agrati, Chiara; Giancola, Maria L.; Alba, Lucia; Grisetti, Susanna; Del Nonno, Franca; Capobianchi, Maria R.; Antinori, Andrea.
In: BMC Infectious Diseases, Vol. 13, No. 1, 600, 21.12.2013.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Brain localization of Kaposi's sarcoma in a patient treated by combination antiretroviral therapy
AU - Baldini, Francesco
AU - Baiocchini, Andrea
AU - Schininà, Vincenzo
AU - Agrati, Chiara
AU - Giancola, Maria L.
AU - Alba, Lucia
AU - Grisetti, Susanna
AU - Del Nonno, Franca
AU - Capobianchi, Maria R.
AU - Antinori, Andrea
PY - 2013/12/21
Y1 - 2013/12/21
N2 - Background: Central nervous system is a very rare site of Kaposi's sarcoma in acquired immunodeficiency syndrome. Kaposi's sarcoma, a neoplasm of endothelial origin, occurs mainly in the skin, but can involve many tissues, especially in patients with a poor immunity. Combination antiretroviral therapy, highly active against human immunodeficiency virus type-1, has caused a dramatic reduction of cutaneous and visceral involvements. No report of central nervous system localization of Kaposi's sarcoma is described since the introduction of combination antiretroviral therapy in the late 90's. Case presentation: A 42 year-old Caucasian man affected by human immunodeficiency virus type-1 infection treated with combination antiretroviral therapy and showing relatively preserved immunity with low viral load presented gingival squamous cell carcinoma and visceral (lungs and lymph nodes) Kaposi's sarcoma. Chemotherapy and radiotherapy were performed with improvement of both neoplasms. Afterwards, a magnetic resonance imaging showed focal lesions of the brain. Despite new chemotherapy and radiotherapy the patient died. Histology after autopsy revealed brain lesions due to Kaposi's sarcoma with the detection of Human Herpesvirus 8 on tissue samples. Conclusions: This is the first report in the combination antiretroviral therapy era of a very rare complication of Kaposi's sarcoma, such as that of brain localization, in a patient with a relatively good control of human immunodeficiency virus infection. Therefore, Kaposi's sarcoma should be considered in differential diagnosis with other intracranial mass lesions that can occur in human immunodeficiency virus infected-patients focusing the issue of appropriate treatment for central nervous system involvement.
AB - Background: Central nervous system is a very rare site of Kaposi's sarcoma in acquired immunodeficiency syndrome. Kaposi's sarcoma, a neoplasm of endothelial origin, occurs mainly in the skin, but can involve many tissues, especially in patients with a poor immunity. Combination antiretroviral therapy, highly active against human immunodeficiency virus type-1, has caused a dramatic reduction of cutaneous and visceral involvements. No report of central nervous system localization of Kaposi's sarcoma is described since the introduction of combination antiretroviral therapy in the late 90's. Case presentation: A 42 year-old Caucasian man affected by human immunodeficiency virus type-1 infection treated with combination antiretroviral therapy and showing relatively preserved immunity with low viral load presented gingival squamous cell carcinoma and visceral (lungs and lymph nodes) Kaposi's sarcoma. Chemotherapy and radiotherapy were performed with improvement of both neoplasms. Afterwards, a magnetic resonance imaging showed focal lesions of the brain. Despite new chemotherapy and radiotherapy the patient died. Histology after autopsy revealed brain lesions due to Kaposi's sarcoma with the detection of Human Herpesvirus 8 on tissue samples. Conclusions: This is the first report in the combination antiretroviral therapy era of a very rare complication of Kaposi's sarcoma, such as that of brain localization, in a patient with a relatively good control of human immunodeficiency virus infection. Therefore, Kaposi's sarcoma should be considered in differential diagnosis with other intracranial mass lesions that can occur in human immunodeficiency virus infected-patients focusing the issue of appropriate treatment for central nervous system involvement.
KW - Central nervous system
KW - Combination antiretroviral therapy
KW - HHV-8
KW - HIV
KW - Kaposi's sarcoma
UR - http://www.scopus.com/inward/record.url?scp=84890478159&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84890478159&partnerID=8YFLogxK
U2 - 10.1186/1471-2334-13-600
DO - 10.1186/1471-2334-13-600
M3 - Article
C2 - 24359263
AN - SCOPUS:84890478159
VL - 13
JO - BMC Infectious Diseases
JF - BMC Infectious Diseases
SN - 1471-2334
IS - 1
M1 - 600
ER -